Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $228.80 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $79.81 | 3 | $0 (2024) |
| Averitas Pharma Inc. | $36.69 | 2 | $0 (2023) |
| Avadel CNS Pharmaceuticals, LLC | $22.09 | 1 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $18.93 | 1 | $0 (2024) |
| Genentech USA, Inc. | $18.36 | 1 | $0 (2024) |
| Bioventus LLC | $18.00 | 1 | $0 (2023) |
| Nevro Corp. | $18.00 | 1 | $0 (2024) |
| TRICE MEDICAL, INC. | $16.92 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107.88 | 5 | ABBVIE INC. ($30.50) |
| 2023 | $120.92 | 6 | AbbVie Inc. ($49.31) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.93 | General |
| Category: Opioid Analgesic | ||||||
| 10/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/31/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 02/26/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Bioventus LLC | Supartz FX Sodium Hyaluronate (Device) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Not Applicable | ||||||
| 10/23/2023 | TRICE MEDICAL, INC. | — | Food and Beverage | In-kind items and services | $16.92 | General |
| 07/18/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/11/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/26/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/01/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 237 | 339 | $58,970 | $26,566 |
| 2022 | 3 | 108 | 171 | $33,713 | $14,569 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 85 | $14,790 | $7,401 | 50.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 42 | $13,601 | $5,519 | 40.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 92 | $11,616 | $5,254 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 37 | $6,290 | $3,456 | 54.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,553 | $1,452 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,003 | $1,394 | 46.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 24 | 40 | $4,120 | $1,349 | 32.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $1,997 | $742.56 | 37.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 45 | $14,805 | $6,666 | 45.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 68 | $11,832 | $4,784 | 40.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 58 | $7,076 | $3,120 | 44.1% |
About Dr. Jensen Swampillai, DO
Dr. Jensen Swampillai, DO is a Physical Medicine & Rehabilitation healthcare provider based in East Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1891287686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jensen Swampillai, DO has received a total of $228.80 in payments from pharmaceutical and medical device companies, with $107.88 received in 2024. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($228.80).
As a Medicare-enrolled provider, Swampillai has provided services to 345 Medicare beneficiaries, totaling 510 services with total Medicare billing of $41,135. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location East Lansing, MI
- Active Since 06/06/2018
- Last Updated 06/27/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891287686
Products in Payments
- BOTOX (Biological) $49.31
- QUTENZA (Drug) $36.69
- UBRELVY (Drug) $30.50
- LUMRYZ (Drug) $22.09
- XTAMPZA (Drug) $18.93
- Ocrevus Zunovo (Biological) $18.36
- Senza (Device) $18.00
- Supartz FX Sodium Hyaluronate (Device) $18.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in East Lansing
Dr. Mathew Saffarian, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $15,342
Ryan O'connor, Do, DO
Physical Medicine & Rehabilitation — Payments: $3,547
Nathan Condie, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $2,472
Pavel Volkov, Do, DO
Physical Medicine & Rehabilitation — Payments: $929.96
John Hawkins, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $850.07
Joshua Gage, Do, DO
Physical Medicine & Rehabilitation — Payments: $508.69